Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-09-13 08:30 am Purchase |
2021-09-02 | 13G | BriaCell Therapeutics Corp. BCTX |
K.J. Harrison & Partners Inc | 63,991 6.230% |
63,991 (New Position) |
Filing History |
| 2021-09-07 4:05 pm Unchanged |
2021-09-01 | 13D | BriaCell Therapeutics Corp. BCTX |
L5 Capital Inc. | 102,000 10.000% |
0 (Unchanged) |
Filing History |
| 2021-08-17 4:04 pm Purchase |
2021-08-09 | 13G | BriaCell Therapeutics Corp. BCTX |
Lynwood Capital Management Inc. | 58,667 5.800% |
58,667 (New Position) |
Filing History |
| 2021-08-09 06:01 am Purchase |
2021-08-06 | 13D | BriaCell Therapeutics Corp. BCTX |
Hyperscale Data Inc. GPUS |
59,000 6.150% |
59,000 (New Position) |
Filing History |
| 2021-08-04 09:43 am Purchase |
2021-08-03 | 13G | BriaCell Therapeutics Corp. BCTX |
L5 Capital Inc. | 102,000 10.000% |
53,667 (+111.03%) |
Filing History |
| 2021-06-28 4:15 pm Purchase |
2021-06-21 | 13G | BriaCell Therapeutics Corp. BCTX |
L5 Capital Inc. | 48,333 5.010% |
48,333 (New Position) |
Filing History |
| 2021-06-14 1:14 pm Purchase |
2021-06-03 | 13G | BriaCell Therapeutics Corp. BCTX |
CVI Investments, Inc. | 40,000 5.000% |
40,000 (New Position) |
Filing History |
| 2021-03-08 4:16 pm Purchase |
2021-02-24 | 13G | BriaCell Therapeutics Corp. BCTX |
Altium Capital Management LLC | 33,333 8.900% |
33,333 (New Position) |
Filing History |
| 2021-03-05 4:13 pm Purchase |
2021-02-26 | 13G | BriaCell Therapeutics Corp. BCTX |
L1 Capital Global Opportunities Master Fund, Ltd. | 66,667 16.300% |
66,667 (New Position) |
Filing History |
| 2021-03-03 07:43 am Purchase |
2021-02-24 | 13G | BriaCell Therapeutics Corp. BCTX |
SABBY MANAGEMENT LLC | 37,000 11.000% |
37,000 (New Position) |
Filing History |
| 2021-03-02 12:06 pm Purchase |
2021-02-23 | 13G | BriaCell Therapeutics Corp. BCTX |
Empery Asset Management, LP | 34,094 8.890% |
34,094 (New Position) |
Filing History |
| 2021-02-26 5:02 pm Purchase |
2021-02-26 | 13G | BriaCell Therapeutics Corp. BCTX |
Lind Global Macro Fund LP | 37,507 9.900% |
37,507 (New Position) |
Filing History |
| 2021-02-26 09:02 am Purchase |
2021-02-23 | 13G | BriaCell Therapeutics Corp. BCTX |
BIGGER CAPITAL FUND L P | 149,000 9.800% |
149,000 (New Position) |
Filing History |